Literature DB >> 15544797

Application of oxidants to the spectrophotometric determination of amlodipine besylate in pharmaceutical formulations.

Nafisur Rahman1, Manisha Singh, Md Nasrul Hoda.   

Abstract

Three new spectrophotometric methods for the determination of amlodipine besylate have been proposed. The first two methods, i.e. A and B, are based on the oxidation of the drug with Fe(III) and the estimation of Fe(II) produced after chelation with either 1,10-phenanthroline or 2,2'-bipyridyl at 500 and 515 nm, respectively. The Beer's law was obeyed in the concentration ranges of 2-10 and 4-14 microg ml(-1) with molar absorptivity of 2.9 x 10(4) and 2.7 x 10(4) l mol(-1) cm(-1) for methods A and B, respectively. The third procedure depends on the interaction of amlodipine besylate with ammonium heptamolybdate tetrahydrate, which resulted in the formation of molybdenum blue (lambda(max) 825 nm). The linear dynamic range and the molar absorptivity values were found to be 15-59 microg ml(-1) and 1.8 x 10(4) l mol(-1) cm(-1), respectively. The results of the proposed procedures were validated statistically and compared with those obtained by the reference method. The proposed methods were applied successfully to the determination of amlodipine besylate in commercial tablets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15544797     DOI: 10.1016/j.farmac.2004.07.009

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  3 in total

1.  Kinetic spectrophotometric method for determination of amlodipine besylate in its pharmaceutical tablets.

Authors:  Ashraf M Mahmoud; Hanaa M Abdel-Wadood; Niveen A Mohamed
Journal:  J Pharm Anal       Date:  2012-03-15

2.  Spectrophotometric determination of etodolac in pure form and pharmaceutical formulations.

Authors:  Ayman A Gouda; Wafaa S Hassan
Journal:  Chem Cent J       Date:  2008-04-14       Impact factor: 4.215

3.  Development of UV spectrophotometry methods for concurrent quantification of amlodipine and celecoxib by manipulation of ratio spectra in pure and pharmaceutical formulation.

Authors:  Mahesh Attimarad; Venugopla Katarigatta Narayanswamy; Bandar Essa Aldhubaib; Nagaraja SreeHarsha; Anroop Balachandran Nair
Journal:  PLoS One       Date:  2019-09-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.